X4 Pharmaceuticals, Inc
XFOR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501697
In the last 90 days, X4 Pharmaceuticals, Inc insiders filed 0 open-market purchases and 2 sales; 89 institutions reported holding it in 13F filings for Q2 2026, worth $463.0M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding X4 Pharmaceuticals, Inc changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 94 | 52 | −42 |
| SharesConverted for a 1-for-30 split | 3.29M | 2.80M | −482.5K (−14.7%) |
| Value | $23.3M | $5.33M | −$18.0M (−77.2%) |
New holders (11)
Institutions that held X4 Pharmaceuticals, Inc at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gsa Capital Partners LLP | 132,724 | $252.0K | 0.02% |
| Jane Street Group, LLC | 97,344 | $185.0K | 0.00% |
| Squarepoint Ops LLC | 38,982 | $74.1K | 0.00% |
| Russell Investments Group, Ltd. | 9,727 | $18.5K | 0.00% |
| SRS Capital Advisors, Inc. | 1,120 | $2.13K | 0.00% |
| Federated Hermes, Inc. | 149 | $283 | 0.00% |
| Nisa Investment Advisors, LLC | 139 | $264 | 0.00% |
| Raymond James Financial Inc | 66 | $125 | 0.00% |
| Clearstead Advisors, LLC | 64 | $122 | 0.00% |
| IFP Advisors, Inc | 0 | $90 | 0.00% |
| True Wealth Design, LLC | 3 | $6 | 0.00% |
Sold out (53)
Institutions that held X4 Pharmaceuticals, Inc at the end of Q1 2025 and filed for Q2 2025 without it.